Kagoshima University Hospital, located in Sakuragaoka, Kagoshima City, Kagoshima Prefecture, provides advanced medical services as a core healthcare institution in the region. In 2019, the hospital was designated as one of the base hospitals for cancer genomic medicine by the national government, and is authorized to perform cancer gene panel testing, interpret results, provide diagnoses, and conduct drug therapy based on those findings. To support this system, the hospital has established a cancer genomic medicine department, with testing operations managed by Department Director Shinsuke Suzuki. Human cells contain approximately 20,000 genes, and in many solid tumors, hundreds of gene abnormalities—representing 1-2% of these genes—are involved in cancer development. The hospital comprehensively examines over 100 treatment-related cancer genes to provide information on the most suitable anticancer drugs for individual patients. Operating hours are weekdays from 8:30 AM to noon and noon to 5:00 PM, with closures on weekends, holidays, and the year-end/New Year period (December 29 to January 3). The facility is equipped with parking and barrier-free access, accommodating visitors arriving by car or using wheelchairs. Payment methods include credit cards, debit cards, and electronic payments. For communication, the hospital supports multiple languages including English and Korean, serving a diverse patient population.